Dr. Rothberg is Director of the Molecular Diagnostics Section of the Strong Health clinical laboratories. The Molecular Diagnostics Section uses the techniques of molecular biology to aid in the diagnosis of human disease. Dr. Rothberg is responsible for the planning and development of laboratory te...
Dr. Rothberg is Director of the Molecular Diagnostics Section of the Strong Health clinical laboratories. The Molecular Diagnostics Section uses the techniques of molecular biology to aid in the diagnosis of human disease. Dr. Rothberg is responsible for the planning and development of laboratory tests that support the care of patients with inherited disease, cancer and infectious disease. His research interests include the development of new testing strategies for the measurement of minimal residual disease in cancer patients, and the development of methods to predict response to therapy.
Faculty Appointments
Professor Emeritus
-
Department of Pathology and Laboratory Medicine (SMD)
Credentials
Post-doctoral Training & Residency
National Institutes of Health Postdoctoral Trainee, Special Fellow of the Leukemia Society of America, Institute for Cancer Research, Fox Chase Cancer Center. Advisor: S. M. Astrin 1982 - 1985
Education
PhD | St Univ at Stony Brook.Molecular Biology.1981
BA | Cuny Queens College.Chemistry.1976
Research
Dr. Rothberg's research focuses on deciphering the role of human genetic variation in the development of disease. Particular areas of focus include cancer and neurodegeneration. Current areas of investigation include studies on the molecular genetics of neuronal ceroid lipofuscinosis (Batten disease...
Dr. Rothberg's research focuses on deciphering the role of human genetic variation in the development of disease. Particular areas of focus include cancer and neurodegeneration. Current areas of investigation include studies on the molecular genetics of neuronal ceroid lipofuscinosis (Batten disease) in collaboration with the Batten Disease Clinical and Research Center, the early prediction of drug resistance in chronic myeloid leukemia, and the role of germline variation in the prognosis of prostate cancer.
Simon RA, Laughlin TS, Nuccie B, Wang N, Rothberg PG, Wang X
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.. 2008 July 27 (3):407-11. Epub 1900 01 01.
Marshall FJ, de Blieck EA, Mink JW, Dure L, Adams H, Messing S, Rothberg PG, Levy E, McDonough T, DeYoung J, Wang M, Ramirez-Montealegre D, Kwon JM, Pearce DA
Neurology.. 2005 July 2665 (2):275-9. Epub 1900 01 01.